Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

NCT02627573 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Leukemia, Chronic Myeloid
Myelodysplastic Syndromes
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Interventions

PROCEDURE: Unrelated allogeneic stem cell transplantation
DRUG: Busulfan
DRUG: Fludarabine monophosphate
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: Cyclophosphamide
DRUG: Thymoglobulin

Sponsor

St. Petersburg State Pavlov Medical University